What clinical trials are currently recruiting in New Mexico?

TrialFinder lists 383 recruiting clinical trials with sites in or near New Mexico. Results cover a wide range of conditions and are updated regularly from ClinicalTrials.gov.

Do I need insurance to join a clinical trial in New Mexico?

No. Study-related care is covered by the trial sponsor at no cost to participants. This includes the experimental treatment, required lab tests, and study visits. Many trials also provide compensation for time and travel. Health insurance is not required to search or enroll.

What conditions have clinical trials recruiting in New Mexico?

Trials in New Mexico cover a broad range of conditions including cancer, diabetes, heart disease, neurological disorders, autoimmune diseases, mental health conditions, and more. Use TrialFinder to search by specific condition and location.

How do I sign up for a clinical trial in New Mexico?

Find a trial that matches your condition on TrialFinder, review the eligibility criteria, and contact the research site listed on the trial detail page. Most research teams will conduct a brief phone pre-screening before any in-person visit. You can also create a free TrialFinder profile to get matched to recruiting trials near you.

383 Recruiting Trials

Clinical Trials in New Mexico

Browse 383 recruiting clinical trials currently enrolling participants in New Mexico. Search by condition to find trials you may qualify for — at no cost.

Showing 15 of 383 recruiting trials in New Mexico

A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies

PHASE1 Duarte, California +4 sites · Ovarian Cancer, Endometrial Cancer

Recruiting

Study of Sacituzumab Govitecan Versus Standard of Care in Participants With Previously Treated Extensive Stage Small Cell Lung Cancer

PHASE3 Anchorage, Alaska +4 sites · Extensive Stage Small Cell Lung Cancer (ES-SCLC)

Recruiting

A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine

PHASE3 Birmingham, Alabama +4 sites · Acute Migraine

Recruiting

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

PHASE3 Anchorage, Alaska +4 sites · Lung Non-Small Cell Carcinoma, Stage II Lung Cancer AJCC v8

Recruiting

APOLLO: A Randomized Phase II Double-Blind Study of Olaparib Versus Placebo Following Curative Intent Therapy in Patients With Resected Pancreatic Cancer and a Pathogenic BRCA1, BRCA2 or PALB2 Mutation

PHASE2 Anchorage, Alaska +4 sites · Resectable Pancreatic Adenocarcinoma, Pancreatic Acinar Cell Carcinoma

Recruiting

Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or Carcinosarcoma

PHASE3 Birmingham, Alabama +4 sites · Endometrial Carcinoma, Endometrial Clear Cell Adenocarcinoma

Recruiting

Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)

PHASE2 Decatur, Alabama +4 sites · Atherosclerotic Cardiovascular Disease, End Stage Kidney Disease

Recruiting

Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)

PHASE2 Birmingham, Alabama +4 sites · Acute Myeloid Leukemia

Recruiting

A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab

PHASE3 Birmingham, Alabama +4 sites · Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8

Recruiting

Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Removal of the Bladder, Kidney, Ureter, and Urethra for Urothelial Cancer Treatment, MODERN Study

PHASE2 Phoenix, Arizona +4 sites · Muscle Invasive Bladder Urothelial Carcinoma, Stage IV Bladder Urothelial Carcinoma AJCC v7

Recruiting

Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)

PHASE2 Birmingham, Alabama +4 sites · Acute Myeloid Leukemia

Recruiting

Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial

PHASE3 Jonesboro, Arkansas +4 sites · Lung Non-Small Cell Carcinoma, Stage II Lung Cancer AJCC v8

Recruiting

A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy

PHASE3 Chandler, Arizona +4 sites · Age-related Macular Degeneration (AMD), Geographic Atrophy (GA)

Recruiting

A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic Medicines

PHASE3 Chandler, Arizona +4 sites · Psoriatic Arthritis

Recruiting

DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer

PHASE3 Tucson, Arizona +4 sites · Endometrial Cancer

Recruiting

See all 383 results in New Mexico

Check Your Eligibility

Create a free profile and our AI will match you to trials in New Mexico you may qualify for.

Get Matched — Free

No insurance required

Search by Condition in New Mexico

Diabetes Cancer Breast Cancer Depression Anxiety Alzheimer's Heart Disease Asthma Multiple Sclerosis Obesity Parkinson's Lupus Hypertension COPD Stroke Arthritis Kidney Disease COVID-19

Browse Other States

California Texas New York Florida Illinois Pennsylvania Ohio Georgia North Carolina Michigan New Jersey Washington Arizona Massachusetts Tennessee Colorado Minnesota Maryland Wisconsin Oregon